Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ST-Segment Elevation Myocardial Infarction.

Yerem Yeghiazarians1, Peter H. Stone

  • 1Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. yyeghiazarians@partners.org

Current Treatment Options in Cardiovascular Medicine
|January 17, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A self-supervised machine learning pipeline for extracting information from live cell images at multiple doses and timepoints.

Scientific reports·2026
Same author

Cardiology Assessment of Patients Undergoing Evaluation for Orthotopic Liver Transplantation.

Journal of the Society for Cardiovascular Angiography & Interventions·2024
Same author

International Consensus Statement on Obstructive Sleep Apnea.

International forum of allergy & rhinology·2022
Same author

Is Vitamin D Supplementation an Effective Treatment for Hypertension?

Current hypertension reports·2022
Same author

Interleukin-15 modulates the response of cortical neurons to ischemia.

Molecular and cellular neurosciences·2021
Same author

Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Circulation·2021
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Rapid reperfusion is critical for ST-elevation myocardial infarction (MI) survival. Prompt treatment with oxygen, aspirin, and reperfusion therapy, either catheter-based or thrombolysis, improves outcomes in acute MI patients.

Area of Science:

  • Cardiology
  • Emergency Medicine

Background:

  • ST-segment elevation myocardial infarction (MI) is a life-threatening emergency.
  • Timely reperfusion significantly improves survival rates in acute MI patients.

Purpose of the Study:

  • To outline the critical steps and therapeutic options for managing ST-elevation myocardial infarction.
  • To emphasize the importance of rapid coronary reperfusion and secondary prevention strategies.

Main Methods:

  • Initial management includes oxygen, aspirin, nitroglycerin, beta-blockers, heparin, and analgesics.
  • Reperfusion therapy options include primary percutaneous coronary intervention (PCI) or thrombolysis.
  • Adjunctive therapies like glycoprotein IIb/IIIa inhibitors are considered.
  • Post-MI assessment includes left ventricular function evaluation and exercise testing.

Related Experiment Videos

Main Results:

  • Catheter-based reperfusion is preferred if available within 60-90 minutes.
  • Thrombolysis is an alternative when timely PCI is not feasible.
  • Glycoprotein IIb/IIIa inhibitors show benefit with PCI and potentially with thrombolysis.
  • Coronary angiography is indicated for failed thrombolysis or recurrent ischemia.

Conclusions:

  • Expedited reperfusion is paramount in ST-elevation MI management.
  • Comprehensive secondary prevention strategies are essential for long-term patient outcomes.
  • Risk factor modification, including smoking cessation and medication, is crucial after MI.